Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eisai
Pharma
Takeda, Enhertu, East Asian American execs—Fierce Pharma Asia
Takeda named Julie Kim as its next CEO. AZ and Daiichi's Enhertu nabbed a new FDA nod. East Asian Americans are underrepresented in C-suites. And more.
Angus Liu
Jan 31, 2025 8:53am
Merck, Eisai combo misses survival goal in GI cancer trial
Jan 24, 2025 10:26am
Analysts tip Lilly to drive eightfold Alzheimer's market boom
Jan 17, 2025 9:00am
Merck's GLP-1 play; Astellas' AAV deal—Fierce Pharma Asia
Dec 20, 2024 8:51am
China cuts, CSL site closure and Kyowa deal—Fierce Pharma Asia
Nov 22, 2024 3:00am
Eisai ends lorcaserin development in Dravet syndrome
Nov 18, 2024 10:18am
